Your browser doesn't support javascript.
loading
Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis.
Pascual, Tomás; Gonzalez-Farre, Blanca; Teixidó, Cristina; Oleaga, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Nuria; Riu, Gisela; Adamo, Barbara; Galván, Patricia; Vidal, Maria; Soy, Dolors; Urbano, Álvaro; Muñoz, Monserrat; Prat, Aleix.
Afiliação
  • Pascual T; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Gonzalez-Farre B; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Teixidó C; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Oleaga L; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Oses G; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Ganau S; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Chic N; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Riu G; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Adamo B; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Galván P; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Vidal M; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Soy D; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Urbano Á; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Muñoz M; Hospital Clinic of Barcelona, Barcelona, Spain.
  • Prat A; Hospital Clinic of Barcelona, Barcelona, Spain.
JCO Precis Oncol ; 3: 1-6, 2019 Dec.
Article em En | MEDLINE | ID: mdl-35100699

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article